(1) In the legend to Figure 2, the symbol for type II collagen should be an open rhombus. (2) In the legend to Figure 6, the open circle is the symbol for native Eu3+-LDL; the open rhombus for oxEu3+-LDL, REM 2.0, 4 hours oxidation; and the open triangle for oxEu3+-LDL, REM 4.9, 24 hours oxidation. (3) In the legend to Figure 7, third line from above, the open triangle is the symbol for fibronectin.
Joachim Greilberger Otto Schmut Günther Jürgens
Medical School, Karl-Franzens
Universität Graz, Austria
In Table 1 of our article entitled "Serum total, free IGF-I, and IGFBP-1 levels in an elderly population: relation to cardiovascular risk factors and disease" by J.A.M.J.L. Janssen, R.P. Stolk, H.A.P. Pols, D.E. Grobbee, and S.W.J. Lamberts (Arterioscler Thromb Vasc Biol. 1998;18:277282), an error has occurred in Table 1 on page 279. The mean free IGF-I level must be 0.092 (SE 0.004) nmol/L; range, 0.020 to 0.283 instead of 0.074 (SE 0.06) nmol/L; range, 0.02 to 0.28.
J.A.M.J.L. Janssen
Dijkzigt University Hospital
Rotterdam, The Netherlands
In our article entitled "Effect of
-tocopherol
(vitamin E) and ß-carotene supplementation on the incidence of
intermittent claudication in male smokers" (Arterioscler
Thromb Vasc Biol. 1997;17:34753480), a computing error was
found that affected the size of the study population. However, this
error caused no change in the results or conclusions of the study. The
correct figures are as follows:
Twenty-six thousand eight hundred seventy-two participants of the ATBS
Study had no intermittent claudication at baseline, and during
follow-up, 2578 new cases of intermittent claudication were observed.
Compared with placebo, the adjusted relative risk for typical
intermittent claudication among those who received
-tocopherol was
1.11 (95% confidence interval, 0.99 to 1.23); among those who received
both
-tocopherol and ß-carotene, 1.04 (0.93 to 1.16); and among
those who received ß-carotene, 1.01 (0.90 to 1.13).
Markareetta Törnwall
National Public Health Institute
Helsinki, Finland
In our article entitled "Thrombin-induced thromboxane synthesis by human platelets: properties of an anion binding exosite Iindependent receptor" by Ruth Ann Henriksen, Gennady P. Samokhin, and Paula B. Tracy (Arterioscler Thromb Vasc Biol. 1997;17:35193526), several errors were introduced during the correction stage. The correct text is as follows:
(1) In the first paragraph on page 3520, the mutation in Thrombin
Quick I should be Arg382(67)
Cys, where 382 indicates the position in
the prothrombin sequence and 67 is the corresponding position in the
chymotrypsinogen sequence. (2) The paragraph on page 3523 that appears
just before the heading Effects of the Protein Kinase Inhibitor
Genistein should read as follows:
The previous observation that treatment of platelets with 2.3 nmol/L thrombin for 5 minutes results in a >90% decrease in antibody binding to the PAR-1 cleavage site36 suggests that functional PAR-1 would not be present after initial treatment with thrombin (Figure 2B) and is consistent with our conclusion that thrombin stimulation of platelets can occur through two receptors. To further characterize the response to thrombin after stimulation with 5 nmol/L thrombin, [Ca2+]i flux, known to be stimulated by thrombin through PAR-1,31 was monitored in platelets loaded with fura 2. When these platelets were treated with 5 nmol/L thrombin for 2 minutes, the addition of 100 nmol/L thrombin resulted in no additional [Ca2+]i flux. Thus, maximal thromboxane production is observed in response to thrombin in the absence of any additional [Ca2+]i flux, further differentiating two platelet responses to thrombin.
Ruth Ann Henriksen
East Carolina School of Medicine
Greenville, North Carolina
In our article entitled "Factors of the metabolic syndrome: baseline interrelationships in the first follow-up cohort of the HDDRISC Study (HDDRISC-1)" by Francisco Leyva, Ian F. Godsland, Melek Worthington, Christopher Walton, and John C. Stevenson (Arterioscler Thromb Vasc Biol. 1998;18:208214), the first sentence of the Acknowledgments was not complete. Full acknowledgments are as follows:
Financial support for the study was provided by the Heart Disease and Diabetes Research Trust, the Cecil Rosen Foundation, and the John Ellerman Foundation.
Ian Godsland
Imperial College of Science, Technology and Medicine
London, England
This article has been cited by other articles:
![]() |
A. W. van den Beld, M. L. Bots, J. A. M. L. L. Janssen, H. A. P. Pols, S. W. J. Lamberts, and D. E. Grobbee Endogenous Hormones and Carotid Atherosclerosis in Elderly Men Am. J. Epidemiol., January 1, 2003; 157(1): 25 - 31. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1998 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |